Article
Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
The journal of sexual medicine - 1 Apr 2014
Masiran Ruziana, Sidi Hatta, Mohamed Zahurin, Mohd Nazree Nur Elia, Nik Jaafar Nik Ruzyanei, Midin Marhani, Das Srijit, Mohamed Saini Suriati
Abstract excerpt
INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) are known for their sexual side effects. Different SSRIs may affect different areas of sexual function at different rates. AIMS: The study aimed to determine the prevalence of female sexual dysfunction (FSD), its clinical correlates, and association with 5HT2A (rs6311) single nucleotide polymorphisms (SNPs) in patients with major depressive disorder...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.